The Armenian National Assembly’s Health Affairs Committee has postponed a debate on amendments to the law on medicines introduced by the opposition Strong Armenia faction for up to two months to allow lawmakers to revise the bill.
The legislation was presented by Strong Armenia MP Harutyun Harutyunyan, who said it would make it easier for medicines already approved for sale in European Union member states to enter the Armenian market.
Under the proposal, medicines certified by the relevant authorities in EU member states would be eligible for registration in Armenia through a simplified procedure based on a review of documents, rather than a full assessment. The bill would also introduce the legal terms “recognition-based registration” and “documentary assessment.”
Harutyunyan argued that the changes would broaden the range of medicines available in Armenia, improve access for consumers and put downward pressure on prices. He also said the new registration procedure could bring additional revenue into the state budget.
Health Minister Anahit Avanesyan, who spoke against the backdrop of the government’s universal health insurance reforms, said the new system was already encouraging pharmaceutical companies to enter the Armenian market, register their products and supply medicines at more competitive prices.
“Even without any additional measures, the introduction of the system encourages pharmaceutical companies to come to Armenia, register their medicines and supply them. It also prompts them to reconsider their pricing policies, as the state now offers a predictable procurement framework,” Avanesyan said.
She argued that universal health insurance was itself a key instrument for ensuring that medicines remained affordable and accessible to the public, adding that the opposition’s proposed amendments would not deliver the intended results.
Avanesyan also maintained that the issues raised by the bill were already covered by existing regulations.
The committee postponed the debate for up to two months to give the bill’s authors time to revise the proposed amendments.
—
Disclaimer: This article was contributed and translated into English by Emil Lazarian. While we strive for quality, the views and accuracy of the content remain the responsibility of the contributor. Please verify all facts independently before reposting or citing.
Direct link to this article: https://www.armenianclub.com/2026/11/16/armenia-delays-debate-on-opposition-bill-to-ease-drug-registration/